Researchers at Mass General Brigham in Somerville, Mass., have developed an autonomous AI system that screens for signs of cognitive impairment by analyzing routine clinical notes — a tool they say ...

Mass General Brigham is announcing the spinout of AIwithCare, a company founded by researchers from the health system who developed an artificial intelligence (AI) screening tool that significantly ...

Study data reveal how a specific sequence of cancer therapies can improve outcomes for patients with hard-to-treat lymphomas Relapsed/refractory (R/R) mature T and natural killer (NK)-cell lymphomas ...

People who interact with chatbots for emotional support or other personal reasons are more likely to report symptoms of ...

A team of scientists and physicians at Mass General Brigham has developed a single-dose oral cholera vaccine and tested it in a phase 1 clinical trial, with results published in The Lancet Infectious ...

While researchers caution it's not a "one-size-fits-all solution," the news could be helpful for certain Americans.

Despite guideline recommendations and improved access to care, individuals with hypertension are unlikely to measure their ...

A team of Mass General Brigham researchers has developed one of the first fully autonomous artificial intelligence (AI) systems capable of screening for cognitive impairment using routine clinical ...

A team led by investigators at the Mass General Brigham Cancer Institute has discovered that a particular marker on tumor ...

Mass General Brigham Tampa ambulatory partnership launches to expand outpatient services and clinical research on Florida's ...